IPI-145 |
|
| Synonyms: (S)-3-(1-((9H-purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one; IPI-145; IPI 145; IPI-145. INK-1197; INK 1197; INK1197 | |
| Cat. No.: I98050 | CAS No.: 1201438-56-3 |
| MDL.: | Formula: C22H17ClN6O |
| F.W.416.86 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | I98050 | CAS No.: | 1201438-56-3 | |
| MDL: | Formula: | C22H17ClN6O | ||
| F.W.: | 416.86 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Application: | IPI-145, also known as INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms of phosphoinositide-3 kinase (PI3K) with potential immunomodulating and antineoplastic activities. | |||








